Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: Dysbiosis is associated with various systemic disorders including irritable bowel syndrome (IBS). Fecal microbiota transplantation (FMT) might restore intestinal microbial balance. The study aimed to determine the safety and efficacy of FMT in IBS patients, as well as also positive predictors for FMT. METHODS: This was a single-arm, open-label study. Eligible patients were diagnosed based on Rome III Diagnostic Criteria. Fecal materials were administered to the patient via colonoscopy. The primary end point was a change in the Bristol stool form scale at 4 weeks after FMT. Recovery to types 3-4 was considered a clinical response. The secondary end point was a change in intestinal microbiota and psychological status using the Hamilton Rating Scale. RESULTS: Ten patients were enrolled. Six patients achieved a clinical response. The diversity of patients 4 weeks after FMT increased significantly compared with patients before FMT, and that of responding patients was significantly higher than non-responder patients. The abundance of Bifidobacterium in effective donors was significantly higher than in ineffective donors and patients. Psychological status of all patients was significantly improved after FMT. CONCLUSIONS: FMT for patients with IBS is safe, and relatively effective. Bifidobacterium-rich fecal donor may be a positive predictor for successful FMT. Key Summary: (1) Dysbiosis is associated with various gastrointestinal disorders including IBS. (2) FMT has potential to restore intestinal microbial balance. (3) We showed that FMT improved stool form and psychological status of IBS patients. (4) Bifidobacterium-rich donor efficiently induced symbiosis in IBS patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mizuno et al. [90] in open-label, non-randomized, single-center trials found that psychiatric status of IBS patients, assessed using the Hamilton Rating Scale for Depression (HAMD), was significantly improved at 1 month after FMT from healthy donors, but returned to the baseline level after 12 weeks.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [90]
In the citing paper
“Three of the four studies found a significant improvement in anxiety symptoms following FMT [44, 45, 48].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“Although Mizuno et al. found improvement in the anxiety scores as well, it was not significant [44].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Cited by
Items 201–300 of 410
Effect of Dose and Timing of Burdock (Arctium lappa) Root Intake on Intestinal Microbiota of Mice
Watanabe, A., Sasaki, H., Miyakawa, H., Nakayama, Y., Lyu, Y., & Shibata, S. (2020) · Microorganisms · doi:10.3390/microorganisms8020220 · Cited by 28
Kronsten, V. T., & Shawcross, D. L. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114437 · Cited by 27
Bostanghadiri, N., Razavi, S., Shariati, A., Talebi, M., Mirkalantari, S., Razavi, À. E., & Darban‐Sarokhalil, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1302719 · Cited by 27
Chang, J. W., Hsieh, J., Tsai, C.-Y., Chiu, H.-Y., Lin, Y.-F., Wu, C., Shen, Y., Hou, M., Chang, C.-Y., Chen, J.-A., et al. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100698 · Cited by 27
A molecular toolkit for heterologous protein secretion across Bacteroides species
Yeh, Y.-H., Kelly, V. W., Pour, R. R., & Sirk, S. J. (2024) · Nature Communications · doi:10.1038/s41467-024-53845-7 · Cited by 26
Fermented soybean foods and diabetes
Hashimoto, Y., Hamaguchi, M., & Fukui, M. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14088 · Cited by 26
Clinical Management of the Microbiome in Irritable Bowel Syndrome
Andrews, C. N., Sidani, S., & Marshall, J. K. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwz037 · Cited by 26
“These differences may be due to the patient populations, the study methodology or the microbial diversity or donor samples, which has been shown to be a predictor of successful transplantation (116).”
BackgroundMatsuoka, T., Hosomi, K., Park, J., Goto, Y., Nishimura, M., Maruyama, S., Murakami, H., Konishi, K., Miyachi, M., Kawashima, H., et al. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00500-3 · Cited by 26
Butyrate-producing bacteria in pregnancy maintenance: mitigating dysbiosis-induced preterm birth
Uchida, A., Imai, K., Miki, R., Hamaguchi, T., Nishiwaki, H., Ito, M., Ueyama, J., Hattori, S., Tano, S., Fuma, K., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06534-y · Cited by 25
Abdelghafar, Y. A., AbdelQadir, Y. H., Motawea, K. R., Nasr, S. A., Omran, H. A. M., Belal, M. M., Elhashash, M. M., AbdelAzim, A. A., & Shah, J. (2022) · Health Science Reports · doi:10.1002/hsr2.814 · Cited by 25
“1 | INTRODUCTION Irritable bowel syndrome (IBS) is a chronic multifactorial functional gastrointestinal disorder, that develops in the middle or lower parts of the gastrointestinal tract (GIT).(1,2) It is a symptom‐based disorder that is currently clinically diagnosed by Rome criteria.”
BackgroundMore than just a number: the gut microbiota and brain function across the extremes of life
Nuzum, N. D., Deady, C., Kittel‐Schneider, S., Cryan, J. F., O’Mahony, S. M., & Clarke, G. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2418988 · Cited by 25
Host–Microbiota Mutualism in Metabolic Diseases
Fabbiano, S., Suárez-Zamorano, N., & Trajkovski, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00267 · Cited by 25
“Since dysbiotic states are clinically similar regardless of the origin, this therapy is currently being tried also for noninfectious intestinal pathologies, like intestinal bowel disease and IBS (114, 115), with first few randomized trials that suggest, at least for IBS, a recovery in bacterial richness after transpla…”
BackgroundKikuchi, R., Irie, J., Yamada-Goto, N., Kikkawa, E., Seki, Y., Kasama, K., & Itoh, H. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0638-0 · Cited by 25
Jacobson, D. K., Honap, T. P., Ozga, A. T., Méda, N., Kagone, T., Carabin, H., Spicer, P., Tito, R. Y., Obregón-Tito, A. J., Marin-Reyes, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81257-w · Cited by 25
Yoshida, K., Hirano, R., Sakai, Y., Choi, M., Sakanaka, M., Kurihara, S., Iino, H., Xiao, J., Katayama, T., & Odamaki, T. (2021) · Communications Biology · doi:10.1038/s42003-021-02072-7 · Cited by 25
Fuke, N., Yamashita, T., Shimizu, S., Matsumoto, M., Sawada, K., Jung, S., Tokuda, I., Misawa, M., Suzuki, S., Ushida, Y., et al. (2023) · Metabolites · doi:10.3390/metabo13020250 · Cited by 24
Redox-related gaseous mediators in the gastrointestinal tract
Naito, Y., Uchiyama, K., & Takagi, T. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-56 · Cited by 24
Fecal microbiota transfer for bowel disorders: efficacy or hype?
Schmulson, M. J., & Bashashati, M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.012 · Cited by 24
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
Sood, A., Singh, A., Midha, V., Mahajan, R., Kao, D. H., Rubin, D. T., & Bernstein, C. N. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa067 · Cited by 24
Shoji, F., Yamashita, T., Kinoshita, F., Takamori, S., Fujishita, T., Toyozawa, R., Ito, K., Yamazaki, K., Nakashima, N., & Okamoto, T. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061674 · Cited by 24
Features of the gut prokaryotic virome of Japanese patients with Crohn’s disease
Imai, T., Inoüe, R., Nishida, A., Yokota, Y., Morishima, S., Kawahara, M., Kusada, H., Tamaki, H., & Andoh, A. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01882-8 · Cited by 23
The gut microbiome and potential implications for early-onset colorectal cancer
Mukherji, R., & Weinberg, B. A. (2020) · Colorectal Cancer · doi:10.2217/crc-2020-0007 · Cited by 23
Horigome, A., Hashikura, N., Yoshida, K., Xiao, J., & Odamaki, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.913624 · Cited by 23
Hu, X., Zhang, Y., Krämer, M., Kissmann, A., Henkel, M., Weil, T., Knippschild, U., & Rosenau, F. (2022) · Molecules · doi:10.3390/molecules27175693 · Cited by 23
Sheng, Y., Wang, J., Gao, Y., Peng, Y., Li, X., Huang, W., Zhou, H., Liu, R., & Zhang, W. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.047 · Cited by 22
Tamai, S., & Suzuki, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11122981 · Cited by 22
Latent environment allocation of microbial community data
Higashi, K., Suzuki, S., Kurosawa, S., Mori, H., & Kurokawa, K. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006143 · Cited by 22
A new treatment for ulcerative colitis: Intracolonic Bifidobacterium and xyloglucan application
Bozkurt, H. S., & Kara, B. (2020) · European Journal of Inflammation · doi:10.1177/2058739220942626 · Cited by 22
Hertel, J., Fässler, D., Heinken, A., Weiß, F. U., Rühlemann, M. C., Bang, C., Franke, A., Budde, K., Henning, A., Petersmann, A., et al. (2022) · Metabolites · doi:10.3390/metabo12040308 · Cited by 22
Melanoma and brown seaweed: an integrative hypothesis
Teas, J., & Irhimeh, M. R. (2016) · Journal of Applied Phycology · doi:10.1007/s10811-016-0979-0 · Cited by 22
Tanabe, H., Sakurai, K., Kato, T., Kawasaki, Y., Nakano, T., Yamaide, F., Taguchi‐Atarashi, N., Watanabe, M., Ochiai, S., Ohno, H., et al. (2019) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100065 · Cited by 21
Hatayama, K., Ebara, A., Okuma, K., Tokuno, H., Hasuko, K., Masuyama, H., Ashikari, I., & Shirasawa, T. (2023) · Biomedicines · doi:10.3390/biomedicines11071789 · Cited by 21
Elhusein, A. M., & Fadlalmola, H. A. (2022) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000652 · Cited by 20
“Of these, six RCTs and six SaTs were included in our analysis, as shown in the PRISMa flow diagram (aroniadis et al., 2019; Beurden et al., 2020; Cha, Hong, Ko, & Shin, 2020; Christian, Rasmus, Peter, & frank, 2019; El-Salhy, Hatlebakk, Gilja, Bråthen Kristoffersen, & Hausken, 2019; El-Salhy, Casen, Valeur, Hausken, &…”
BackgroundMatsuura, N., Kanayama, M., Watanabe, Y., Yamada, H., Lili, L., & Torii, A. (2024) · Nutrients · doi:10.3390/nu16193333 · Cited by 20
Shinohara, R., Sasaki, K., Inoue, J., Hoshi, N., Fukuda, I., Sasaki, D., Kondo, A., & Osawa, R. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-029 · Cited by 20
Sakurai, K., Kato, T., Tanabe, H., Taguchi‐Atarashi, N., Sato, Y., Eguchi, A., Watanabe, M., Ohno, H., & Mori, C. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13177 · Cited by 20
Oliphant, K., Cochrane, K., Schroeter, K., Daigneault, M. C., Yen, S., Verdu, E. F., & Allen‐Vercoe, E. (2020) · mSystems · doi:10.1128/msystems.00404-19 · Cited by 20
“The efficacy of these therapies in treating such GI disorders, including irritable bowel syndrome (IBS) (6, 7) and inflammatory bowel diseases (IBD) (8–10), overall has been mixed.”
BackgroundOsaki, H., Jodai, Y., Koyama, K., Omori, T., Horiguchi, N., Kamano, T., Funasaka, K., Nagasaka, M., Nakagawa, Y., Shibata, T., et al. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.20407/fmj.2020-021 · Cited by 20
Goto, Y., Nishimoto, Y., Murakami, S., Nomaguchi, T., Mori, Y., Ito, M. A., Nakaguro, R., Kudo, T., Matsuoka, T., Yamada, T., et al. (2022) · Nutrients · doi:10.3390/nu14173468 · Cited by 20
Kono, K., Murakami, Y., Ebara, A., Okuma, K., Tokuno, H., Odachi, A., Ogasawara, K., Hidaka, E., Mori, T., Satoh, K., et al. (2022) · Nutrients · doi:10.3390/nu14183839 · Cited by 20
Hatayama, K., Kono, K., Okuma, K., Hasuko, K., Masuyama, H., & Benno, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020376 · Cited by 19
Genomic and functional diversity of cultivated Bifidobacterium from human gut microbiota
Li, W., Liang, H., He, W., Gao, X., Wu, Z., Hu, T., Lin, X., Wang, M., Zhong, Y., Zhang, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27270 · Cited by 19
Sasaki, H., Lyu, Y., Nakayama, Y., Nakamura, F., Watanabe, A., Miyakawa, H., Nakao, Y., & Shibata, S. (2020) · Microorganisms · doi:10.3390/microorganisms8060954 · Cited by 19
Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
Zhang, X., Ishikawa, D., Ohkusa, T., Fukuda, S., & Nagahara, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1068567 · Cited by 19
García, G., Soto, J., Valenzuela, C., Bernal, M., Penié, J. B., Lorenzo, M. D. C. L., Kazlauskaite, R., Waslidge, N., Bavington, C. D., & Cano, R. J. (2025) · Microorganisms · doi:10.3390/microorganisms13071545 · Cited by 18
“These genera are commonly associated with metabolic health, gut integrity, and immune regulation, indicating that even a modest intervention may create conditions conducive to long-term resilience and host benefit [111,112].”
Faecal microbiota transplantation in children : A systematic review
Lauwers, E., Sabino, J., Hoffman, I. E. A., & van Hoeve, K. (2024) · Acta Paediatrica · doi:10.1111/apa.17167 · Cited by 18
“69 However, for inflammatory conditions, such as IBD and metabolic syndrome, restoration of butyrate-producing taxa by key members within Clostridium clusters IV and XIVa has been associated with prolonged clinical remission in IBD after FMT therapy.”
BackgroundHayashi, K., Uchida, R., Horiba, T., KAWAGUCHI, T., Gomi, K., & Goto, Y. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2023-103 · Cited by 18
Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
Balan, Y., Gaur, A., Sakthivadivel, V., Kamble, B. D., & Sundaramurthy, R. (2021) · Cureus · doi:10.7759/cureus.19740 · Cited by 18
“However, few studies were not in favor of FMT [79-81].”
ResultInfluentialIdentification of Human Gut Microbiome Associated with Enterolignan Production
Sawane, K., Hosomi, K., Park, J., Ookoshi, K., Nanri, H., Nakagata, T., Chen, Y. A., Mohsen, A. S., Kawashima, H., Mizuguchi, K., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10112169 · Cited by 18
From germ theory to germ therapy
Chen, C., Chen, Y., Liou, J., & Wu, M. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12011 · Cited by 18
Chen, H., Jiang, X., Zhu, F., Yang, R., Yu, X., Zhou, X., & Tang, N. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03233-4 · Cited by 17
Baba, H., Kanamori, H., Kudo, H., Kuroki, Y., Higashi, S., Oka, K., Takahashi, M., Yoshida, M., Oshima, K., Aoyagi, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225340 · Cited by 17
Stallmach, A., Grunert, P., Stallhofer, J., Löffler, B., Baier, M., Rödel, J., Kiehntopf, M., Neugebauer, S., Pieper, D. H., Junca, H., et al. (2022) · Trials · doi:10.1186/s13063-022-06095-1 · Cited by 17
Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto, R., Ianiro, G., de Paulis, A., Spadaro, G., Marone, G., Gasbarrini, A., & Varricchi, G. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01006-3 · Cited by 17
The Gut Microbiome and Metabolome of Two Riparian Communities in the Amazon
Pires, E. S., Hardoim, C. C. P., Miranda, K. R., Secco, D., Lobo, L. A., de Carvalho, D. P., Han, J., Borchers, C. H., Ferreira, R. B. R., Salles, J. F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02003 · Cited by 17
Ichikawa, N., Sasaki, H., Lyu, Y., Furuhashi, S., Watabe, A., Imamura, M., Hayashi, K., & Shibata, S. (2021) · Metabolites · doi:10.3390/metabo12010020 · Cited by 16
Borrego-Ruiz, A., & Borrego, J. J. (2024) · SciBase neurology. · doi:10.52768/neurology/1018 · Cited by 16
“In total we have reviewed 28 stud - ies from 2017 to 2023, of which 35.7% corresponded to depres - sion (MDD) and anxiety disorders [61,63,65,66,68,71,74,75,81, 85]; 17.8% to Parkinson’s Disease (PD) [69,76,77,79,83]; 10.7% to Multiple Sclerosis (MS) [64,72,80]; 7.1% to Alzheimer’s Dis - ease (AD)…”
BackgroundInfluentialA Study of Sex Differences in the Biological Pathways of Stress Regulation in Mice
Qiao, Y., Chen, H., Guo, J., Zhang, X., Liang, X., Wei, L., Wang, Q., Bi, H., & Gao, T. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70433 · Cited by 16
“In addition, Lactobacillaceae and Bifidobacteriaceae are probiotics that play an important role in improving general immunity, gastrointestinal infections, and depressive symptoms [65–67].”
Promising new pharmacological targets for depression: The search for efficacy
Tsugiyama, L. E., de Moraes, R. C. M., Moraes, Y. A. C., & de Oliveira, J. F. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103804 · Cited by 16
Nakagome, S., Chinen, H., Iraha, A., Hokama, A., Takeyama, Y., Sakisaka, S., Matsui, T., Kidd, J. R., Kídd, K. K., Said, H. S., et al. (2017) · Human Genetics · doi:10.1007/s00439-017-1764-0 · Cited by 16
Self-citationNanki, K., Mizuno, S., Matsuoka, K., Ono, K., Sugimoto, S., Kiyohara, H., Arai, M., Nakashima, M., Takeshita, K., Saigusa, K., et al. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.1.142 · Cited by 16
Self-citationXu, X., Jin, H., Li, X., Yan, C., Zhang, Q., Yu, X., Liu, Z., Liu, S., & Zhu, F. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10344-x · Cited by 15
Clancy, A. K., Gunaratne, A. W., & Borody, T. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.653653 · Cited by 15
“For example, donor stool rich in bifidobacterium, known to be enhanced by a fibre rich diet (44), was associated with increased therapeutic efficacy of FMT in patients with IBS (45).”
BackgroundInfluentialTakihara, H., & Okuda, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1137303 · Cited by 15
Hirano, R., Nishita, I., Nakai, R., Bito, A., Sasabe, R., & Kurihara, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1056866 · Cited by 15
Our Microbiome: On the Challenges, Promises, and Hype
Federici, S., Suez, J., & Elinav, E. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_20 · Cited by 15
Smith, D. A., Jheeta, S., Fuentes, H. V., & Palacios-Pérez, M. (2022) · Life · doi:10.3390/life12081197 · Cited by 15
“Although faecal transplantation procedure is usually employed in the intestine of an adult recipient [27,97], in principle it would be more effective if the missing microbiota could be applied directly on to the head of the new-born, thus replicating the process of maternal microbial inheritance [143].”
BackgroundMiso, fermented soybean paste, suppresses high-fat/high-sucrose diet-induced muscle atrophy in mice
Hashimoto, Y., Okamura, T., Bamba, R., Yoshimura, Y., Munekawa, C., Kaji, A., Miki, A., Majima, S., Senmaru, T., Ushigome, E., et al. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-36 · Cited by 14
Wen, B., Huang, Y., Deng, G., Yan, Q., & Jia, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05764-w · Cited by 14
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)
Krynicka, P., Koulaouzidis, G., Marlicz, W. M., & Koulaouzidis, A. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2508967 · Cited by 14
“Such advancements could increase FMT efficacy for patients with treatment-refractory IBS and FD [86].”
Kato, T., Kagawa, M., Suda, W., Tsuboi, Y., Inoue-Suzuki, S., Kikuchi, J., Hattori, M., Ohta, T., & Ohno, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911728 · Cited by 14
Self-citationMatsunaga, M., Takeuchi, M., Watanabe, S., Takeda, A., Kikusui, T., Mogi, K., Nagasawa, M., Hagihara, K., & Myowa, M. (2024) · Communications Biology · doi:10.1038/s42003-024-05884-5 · Cited by 14
Mechanism of Microbiota-Gut-Brain in Perimenopausal Depression: An Inflammatory Perspective
Yu, X., Zuo, Y., Yang, Y., Cheng, W., Shi, M., Cheng, L., Shao, Q., Xu, Y., & Chen, L. (2025) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2025.10011 · Cited by 13
Oguri, N., Kobayashi, C., Ozawa, Y., Kimura, T., Nishinarita, Y., Wada, H., Nemoto, N., Narita, M., Tanigaki, S., Hanawa, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63466-3 · Cited by 13
Kawamura, A., Nemoto, K., & Sugita, M. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001805 · Cited by 13
Influence of changes in the intestinal microflora on the immune function in mice
Kishida, S., Kato‐Mori, Y., & Hagiwara, K. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.17-0485 · Cited by 13
Classification of the Occurrence of Dyslipidemia Based on Gut Bacteria Related to Barley Intake
Maruyama, S., Matsuoka, T., Hosomi, K., Park, J., Nishimura, M., Murakami, H., Konishi, K., Miyachi, M., Kawashima, H., Mizuguchi, K., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.812469 · Cited by 13
A proposal for the reference intervals of the Italian microbiota “scaffold” in healthy adults
Sisti, D., Pazienza, V., Piccini, F., Citterio, B., Baffone, W., Zeppa, S. D., Biavasco, F., Prospero, E., Luca, A. D., Artico, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08000-x · Cited by 13
Yan, Q., Jia, L., Wen, B., Wu, Y., Zeng, Y., & Wang, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.919010 · Cited by 13
Reygner, J., Delannoy, J., Barba-Goudiaby, M.-T., Gasc, C., Levast, B., Gaschet, E., Ferraris, L., Paul, S., Kapel, N., Waligora‐Dupriet, A., et al. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.00016-24 · Cited by 12
“Indeed, it has been demonstrated that differences in donor-derived stool composition translate to major changes in engraftment dynamics, directly affecting treatment efficacy in gastrointesti nal disorders (27–29).”
BackgroundNadai, R. D., de Melo, C., Custódio, J. P., Ferreira, F. B., Clara, A., Trindade, L. Z., Martins, F. Q., & Signorelli, I. V. (2018) · Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo · doi:10.26432/1809-3019.2017.62.3.156 · Cited by 12
“Além destas vantagens nos sintomas diretamente vinculados à síndrome, os pacientes que realizaram o TMF tiveram melhora no status psicológico, segundo o estudo de Mizuno et al, 2017(16) que utilizou a escala de Hamilton Rating.”
BackgroundTaxonomic Distribution of FosB in Human-Microbiota and Activity Comparison of Fosfomycin Resistance
Song, Z., Wang, X., Zhou, X., Jiang, S., Li, Y., Ahmad, O., Qi, L., Li, P., & Li, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00200 · Cited by 12
An Updated Narrative Mini-Review on the Microbiota Changes in Antenatal and Post-Partum Depression
Doroftei, B., Ilie, O., Diaconu, R., Huțanu, D., Stoian, I. L., & Ilea, C. G. (2022) · Diagnostics · doi:10.3390/diagnostics12071576 · Cited by 12
“[94] revealed that donor material rich in Bifidobacterium stimulates the growth and expansion of strains.”
BackgroundThe necessity of gut microbiome characterization in diseases prevention and therapy.
Rezasoltani, S., Mojarad, E. N., Norouzinia, M., & Aghdaei, H. A. (2017) · Gastroenterology and hepatology from bed to bench. · Cited by 12
Yang, Y., Liu, F., Zeng, D., Chen, Z., Wang, M., Xun, L., & Xia, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114149 · Cited by 11
Li, J., Wang, Y., Li, R., Huang, H., Zhu, X., Li, X., Sun, Z., Zhang, L., Zheng, P., He, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.017 · Cited by 11
The influence of the gut microbiota on B cells in autoimmune diseases
He, L., Li, X., Jiang, S., Ou, Y., Wang, S., Shi, N., Yang, Z., Yuan, J., Silverman, G. J., & Niu, H. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01195-5 · Cited by 11
Administration of Aspergillus oryzae suppresses DSS-induced colitis
Nomura, R., Tsuzuki, S., Kojima, T., Nagasawa, M., Sato, Y., Uefune, M., Baba, Y., Hayashi, T., Nakano, H., Kato, M., et al. (2021) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2021.100063 · Cited by 11
Aumpan, N., Chonprasertsuk, S., Pornthisarn, B., Siramolpiwat, S., Bhanthumkomol, P., Issariyakulkarn, N., Gamnarai, P., Bongkotvirawan, P., Wongcha-um, A., Mahachai, V., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1648944 · Cited by 10
Iida, K., Naiki, T., Etani, T., Nagai, T., Sugiyama, Y., Isobe, T., Aoki, M., Nozaki, S., Noda, Y., Shimizu, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53158-1 · Cited by 10
Hasuda, H., Ikeda, T., Makizaki, Y., Yokota, H., Tanaka, Y., Ohno, H., Shimokawa, M., Matsuoka, H., Kimura, Y., Oki, E., et al. (2022) · Surgery Today · doi:10.1007/s00595-022-02607-3 · Cited by 10
Ramos, R. J., Zhu, C., Joseph, D. F., Thaker, S., LaComb, J. F., Markarian, K., Lee, H., Petrov, J. C., Monzur, F., Buscaglia, J. M., et al. (2022) · Medical Research Archives · doi:10.18103/mra.v10i10.3318 · Cited by 10
Ogasawara, K., Yamada, N., Nakayama, S. M. M., Watanabe, Y., Saito, K., Chiba, A., Uchida, Y., Kaoru, U. E. D. A., TAKENAKA, Y., Kazama, K., et al. (2023) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0138 · Cited by 10
Gut microbiome transfer—Finding the perfect fit
Leong, K. S. W., O'Sullivan, J. M., Derraik, J. G. B., & Cutfield, W. S. (2020) · Clinical Endocrinology · doi:10.1111/cen.14183 · Cited by 10
Marchesi, J. R., Allen, S., Scott, E., Jenkins, H. R., Sadlier, C., & Thomas, S. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2138661 · Cited by 9
Kobatake, E., Iwama, Y., Arai, T., Tsukisaka, Y., & Kabuki, T. (2023) · Nutrients · doi:10.3390/nu15204458 · Cited by 9
Poortmans, P. J., & Kindt, S. (2020) · VUBIR (Vrije Universiteit Brussel) · Cited by 9
The Impact of Diagnostic Status on Quality of Life in Irritable Bowel Syndrome
Cassar, G. E., George Youssef, J., Knowles, S. R., Moulding, R., & Austin, D. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20517 · Cited by 9
Bile Collected From the Normal Gallbladder of Patients During Surgery Has Simple Bacterial Flora
Watanabe, S., Minagawa, M., Shinoda, T., Motooka, D., Tohya, M., Kirikae, T., Nakamura, S., & Saiura, A. (2022) · Cureus · doi:10.7759/cureus.25681 · Cited by 9
Kim, J.-W., Lee, J. S., Kim, J. H., Jeong, J.-W., Lee, D. H., & Nam, S. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0146 · Cited by 9
Metadata
- Authors
- Mizuno, S., Masaoka, T., Naganuma, M., Kishimoto, T., Kitazawa, M., Kurokawa, S., Nakashima, M., Takeshita, K., Suda, W., Mimura, M., Hattori, M., & Kanai, T.
- Affiliations
- Keio University (JP)
- Waseda University (JP)
- ORCID
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 96
- Issue
- 1
- Pages
- 29-38
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- PMC
- PMC5637308
- OpenAlex
- W2657252452
- Cited by
- 395
- References
- 37
- Citations by year
- 2026: 7 · 2025: 28 · 2024: 34 · 2023: 52 · 2022: 76 · 2021: 46 · 2020: 45 · 2019: 41 · 2018: 38 · 2017: 19
- FWCI
- 41.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Digestion (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tokyo Medical and Dental University
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, irritable bowel syndrome, Bifidobacterium, donor selection, predictors of treatment response, gut dysbiosis, stool consistency, psychological state, Hamilton Depression Rating Scale, gut microbiota diversity
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adult, Bifidobacterium, Colonoscopy, Feces, Female, Humans, Intestines, Japan, Male, Middle Aged, Treatment Outcome, Living Donors, Irritable Bowel Syndrome, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.